IBX 12.5% 7.0¢ imagion biosystems limited

Ann: Positive clinical data reported at breast cancer symposium, page-12

  1. 47 Posts.
    lightbulb Created with Sketch. 289
    [EXCITING NEWS] We are thrilled to be sharing real patient data from our Phase I study for our MagSense® HER2 breast cancer imaging agent at the San Antonio Breast Cancer Symposium today.

    Our first-of-its-kind, novel #MagSense imaging agent shows it has the potential to aid in identifying metastatic disease in HER2 breast cancer patients. This data showcases exactly what we've all been working towards!

    Read full announcement: https://imagionbiosystems.com/news/imagion-presents-magsense-interim-study-results-at-breast-cancer-meeting/
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.